Vivodyne started as an idea between Co-Founders Andrei Georgescu (left), now Vivodyne’s CEO, and UPenn Professor Dan Huh (right), now Vivodyne’s CSO, while Andrei performed his Ph.D. graduate studies in Huh’s bioengineering research lab….
Continue Reading
Philadelphia-based AI-enabled biotech company Vivodyne announced it closed a $38 million seed funding round led by Khosla Ventures.CS Ventures, Kairos Ventures, Bison Ventures and MBX Capital also participated in the round.
WHAT THEY DO
Vivodyne is…
From left: Hubert Zajicek, Health Wildcatters CEO and co-founder; Somer Baburek, Hera Biotech CEO; and Katie Adams, MedCity News Senior Reporter.
At the MedCity INVEST Digital Health conference in Dallas, held in collaboration with Health Wildcatters,…
What You Should Know:
Gero, a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round.This funding round positions Gero to continue internal drug development programs, grow its…
Continue Reading
In the relentless global battle against cancer, generative artificial intelligence (Gen AI) has emerged as a powerful tool in oncology’s arsenal. With the capacity to analyse vast datasets, simulate complex molecular interactions, and tailor…
Continue Reading
Multinational biotechnology company Biogen has confirmed it will shut down Biogen Digital Health, a global unit of the biotech company, and pullout of a study with Apple. Still, the company says it will continue…
Continue Reading
Bonfire Analytics, a Startup Offering AI-Driven Lead Scoring and Claims-Based Targeting, has Closed its Pre-Seed Funding Round
New York-based healthtech startup, Bonfire Analytics, has just become venture-backed as they close a pre-seed round. The company…
California-based AI drug discovery startup Genesis announced it scored a whopping $200 million in an oversubscribed Series B funding round, bringing its total raise to $280 million. The company also announced that approximately $24 million…
Continue Reading
What You Should Know: Clario announced an expansion to its collaboration with AliveCor to enable trial participants to collect medical-grade six-lead ECG readings in the comfort of their own homes through KardiaRx, a clinical-trial-focused…
Continue Reading
Dave Hodgson is co-founder and CEO of Project Ronin of San Mateo, CA.
Tell me about yourself and the company.
I’m a molecular biologist by training. I started my first job on the genome project in…
